SCHEMBL6628033

SCHEMBL6628033

COc1cc2cnn(Cc3ccncc3)c(=O)c2cc1OC

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.50
▸ HTT P42858 1/20 0.50
▸ HSD17B10 Q99714 1/20 0.50
▸ AURKA O14965 1/20 0.43
▸ GRK2 P25098 1/20 0.43
▸ ROCK1 Q13464 1/20 0.43
▸ RPS6KA1 Q15418 1/20 0.43
▸ PDE10A Q9Y233 2/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ ROCK2 O75116 1/20 0.43
▸ PDE4B Q07343 3/20 0.42
▸ NPBWR1 P48145 8/20 0.42
▸ PDE4A P27815 2/20 0.42
▸ PDE4C Q08493 2/20 0.42
▸ PDE4D Q08499 2/20 0.42
▸ ERBB2 P04626 1/20 0.41
▸ MCHR1 Q99705 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8596166 0.80 PDE10A (0.41) ALDH1A1HTTHSD17B10PDE10ATDP1
SCHEMBL9873229 0.77 NPC1 (0.41) ALDH1A1HTTHSD17B10PDE10A
SCHEMBL8598436 0.76 TNF (0.41) ALDH1A1HTTHSD17B10PDE10ATDP1
Hydrochloric Acid SCHEMBL9874495 0.74 ALDH1A1 (0.47) ALDH1A1HTTHSD17B10
SCHEMBL9875402 0.74 TNF (0.40) ALDH1A1HTTHSD17B10PDE10APDE4B
SCHEMBL29702360 0.71 LRRK2 (0.50) ALDH1A1HTTHSD17B10PDE10ATDP1
SCHEMBL26100427 0.71 LRRK2 (0.50) ALDH1A1HTTHSD17B10PDE10ATDP1
Ethoxycarbonyl Group SCHEMBL28815733 0.71 PDE10A (0.43) ALDH1A1HTTHSD17B10PDE10APDE4B
SCHEMBL22226011 0.71 NPBWR1 (0.62) AURKAGRK2ROCK1RPS6KA1TDP1
SCHEMBL28899162 0.71 NPBWR1 (0.56) ALDH1A1HTTHSD17B10AURKAGRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1124829-B1 TRICYCLIC PHTHALAZINE DERIVATIVES AS PHOSPHODIESTERASE 4 INHIBITORS ZAMBON SPA (IT) 2004-08-04 — — EP disclosed
US-6525055-B1 Allergic and inflammatory pathologies such as, for example, emphysema, chronic bronchitis, asthma and allergic rhinitis. ZAMBON GROUP S.P.A. (IT) 2003-02-25 — — US disclosed
Send feedback